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Abstract
Recent work suggests a role for multiple host factors in facilitating HIV-1 reverse transcription. Previously, we identified a cellular
activity which increases the efficiency of HIV-1 reverse transcription in vitro. Here, we describe aspects of the activity which shed
light on its function. The cellular factor did not affect synthesis of strong-stop DNA but did improve downstream DNA synthesis.
The stimulatory activity was isolated by gel filtration in a single fraction of the exclusion volume. Velocity-gradient purified HIV-1,
which was free of detectable RNase activity, showed poor reverse transcription efficiency but was strongly stimulated by partially
purified cell proteins. Hence, the cell factor(s) did not inactivate an RNase activity that might degrade the viral genomic RNA and
block completion of reverse transcription. Instead, the cell factor(s) enhanced first strand transfer and synthesis of late reverse
transcription suggesting it stabilized the reverse transcription complex. The factor did notaffect lysisof HIV-1by Triton X-100 in the
endogenous reverse transcription (ERT) system, and ERT reactions with HIV-1 containing capsid mutations, which varied the
biochemical stability of viral core structures and impeded reverse transcription in cells, showed no difference in the ability to be
stimulated by the cell factor(s) suggesting a lack of involvement of the capsid in the in vitro assay. In addition, reverse transcription
products were found to be resistant to exogenous DNase I activity when the active fraction was present in the ERT assay. These
results indicate that the cell factor(s) may improve reverse transcription by facilitating DNA strand transfer and DNA synthesis. It
also had a protective function for the reverse transcription products, but it is unclear if this is related to improved DNA synthesis.
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Introduction
Ap r i o r i , viruses are dependent on their hosts for replication.
Therefore, it is not unexpected that recent studies using si/shRNA
knockdown[1,2,3,4,5]andyeasttwo-hybridscreeningimplicatehost
cell factors in HIV reverse transcription [6,7,8]. Whether knock-
down of the proteins identified in these studies removes a cellular
factor which directly supports the reverse transcription complex
(RTC) in some manner, or perturbs the general cell environment
and ameliorates the replicative functions of the virus machinery
though secondary downstream effects is unknown. It is possible that
a subset of these factors may act by physical association with the
RTC, and evidence of such an association would support a direct
rolefor cellfactors.Changes insizeand shape of the RTCpost-entry
suggest this is likely (reviewed in [9]). In the case of yeast two-hybrid
studies, some of these cell factors are able to bind one of two key
components of the RTC: reverse transcriptase (RT) [7,8] and
integrase (IN) [6,10,11] indicating that they may physically associate
in vivo. Various cell proteins linked to integration have been detected
in extracts or partially-purified material containing pre-integration
complexes (PICs) [12,13,14,15,16]. However, similar experiments
have not been performed for cell factors implicated in reverse
transcription. Therefore, strong evidence for a cell protein which
assists reverse transcription as part of a bona fide complex is lacking.
It is possible that cell factors may transiently act on the RTC to
facilitate reverse transcription without becoming part of the complex.
In the genomic screen performed by Konig et al,m o s to ft h ec e l l
proteins identified to affect reverse transcription were not linked
directly to viral proteins but were instead linked to viral RTC
components through other protein-protein interactions, suggesting
these proteins may be part of large complexes which perform
enzymatic functions on the maturing RTC [2]. These complexes
function in the ubiquitin-proteasome pathway, DNA transcription,
splicing and nucleic acid binding, DNA replication and repair, and
nuclearimport.Ofthemorethan50proteinsidentifiedsofartoaffect
reversetranscription, onlya few haveanactivitythatsuggestsarolein
assisting reverse transcription (reviewed in [9]). For example, cell
proteins with known RNA helicase and DNA repair activities were
identified, and these activities might conceivably be related to
assisting DNA synthesis during reverse transcription [2]. Some of
theseproteins might also becomepart of the RTC as discussed above.
So currently, whilst it is likely that cell factors have such a role, none
has been convincingly shown either to act on, or be part of, the RTC.
In the search for cell factors which support reverse transcription, in
vitrobiochemical systems provide a powerful means to analyze protein
complexes and their activities, which are amenable to further
advance by purification of components by chromatographic and
other methods. Various in vitro reverse transcription systems have
been described for retroviruses over the last three decades, mostly
based on virion delipidation using high detergent concentration and
incorporation of radioactively labelled nucleotides [17,18,19,20,21].
More recently, a system devised for avian sarcoma and leukosis virus
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described an in vitro system based on nascent endogenous reverse
transcription (ERT) of virions delipidated with low concentrations of
non-ionic detergent [23]. The addition of a cytoplasmic lysate
prepared from Jurkat cells to an ERT reaction greatly improved the
synthesis of late HIV-1 reverse transcription products, also suggesting
cellfactorinvolvement. In this workwe applyour in vitro system to the
mechanism of action of the previously described stimulatory cell
factor(s). We provide evidence that the strand transfer and elongation
ability of the reverse transcription complex released by detergent was
improved after addition of lysate. In addition, reverse transcription
products were found to be protected from exogenous nuclease when
the active fraction was present in the reaction. The above suggest
enhanced stability of the RTC by cell factor(s) in the Jurkat lysate in
vitro, which may assist reverse transcription complex in vivo.
Results
Improved first-strand transfer contributes to enhanced
late product synthesis during endogenous reverse
transcription in vitro
Previously, we showed that an activity in a cytoplasmic lysate
(S100) derived from a human T cell line (Jurkat) stimulated the
ability of HIV-1 to generate late endogenous reverse transcription
(ERT) products in vitro in a 22 h reaction [23]. It remains unclear
how S100 affects reverse transcription but the possibilities include
increasing the efficiency of steps such as strand transfer event or
elongation of viral DNA products by RT. To explore this
possibility, a time-course of ERT reactions was performed for an
extended reaction time of 46 h and multiple products of reverse
transcription were measured using quantitative PCR (Fig. 1A–C).
The reaction efficiency was calculated which is expressed as the
percentage of molecules of products generated for every molecule
of negative-strand strong-stop DNA (the first reverse transcription
product). The efficiency of late product synthesis in reactions
without S100 was not increased using the extended reaction time.
As observed previously, second-strand transfer DNA (Fig. 1C), the
last measurable DNA product by conventional PCR methods, was
greatly stimulated compared to earlier products (strong-stop
transfer DNA; Fig. 1A) in the presence of S100. However, first-
strand transfer synthesis was improved (Fig. 1B). As the first-strand
transfer products precede second-strand transfer products in the
synthesis pathway, improved synthesis of first-strand transfer must
contribute to the enhanced reaction efficiency of the second-strand
transfer.
The cell factor(s) do not affect detergent lysis of virions
The ERT reaction is performed in the presence of detergent at a
concentration which we previously demonstrated was sufficient to
lyse virions (0.2 mM Triton X-100) [23]. In determining its
Figure1. Time courseofendogenous reverse transcription (ERT) reactions. Reactions containing detergent-lysedvirions were prepared either
with or without added S100. Reactions were incubated at 37uC for the indicated time, and reaction products analysed by quantitative PCR using the
indicated primer sets (A–C). The experiment was performed in triplicate reactions. The mean value and standard deviation of the mean is shown.
doi:10.1371/journal.pone.0013229.g001
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lysate preparations contained material which retarded the kinetics
of virion lysis such that late product synthesis was favoured in the
ERT reaction. To test this possibility, virions were treated with
detergent (0.2 mM Triton X-100) either with or without S100 for
various times up to 20 h. The amount of sedimentable capsid
protein remaining, as a measure of unlysed virions and cores [24],
was determined by ultracentrifugation and p24 ELISA on the
supernatant and pellet fractions (Fig. 2A and B, respectively).
Virion lysis was rapid: at least 79% of virions were lysed
immediately, as determined by p24 in the supernatant. The
amount of p24 in the supernatant increased only slightly with
further incubation. This contrasted with the untreated control
where .90% of the p24 was in the pellet fraction (data not
shown). Triton-X 100 mediated lysis was identical for reactions
either with or without S100 which indicated that envelope lysis
and capsid core disruption were not affected by addition of cellular
factors that stimulated reverse transcription.
Velocity gradient purification removes a co-purifying
RNase activity
One possible mechanism of action of the cell factor(s) was that
the viral nucleoprotein complex was susceptible to a degradative
activity that was prevented by the addition of S100. Northern
analysis of viral genomic RNA isolated from lysed HIV-1
indicated that a co-purifying nuclease was present in the
sucrose-cushion purified virus preparation (data not shown).
Hence, the virus was subjected to further purification by velocity
gradient ultracentrifugation [25] to separate the virus from
contaminants, such as microvesicles, that might contain nucleases
(Fig. 3A and B). A decrease in viral genomic RNA was detected by
RT-PCR after addition of Triton X-100 to sucrose-cushion
purified virus and incubation at 37uCfor 1 h, indicating an RNase
in this preparation was able to access viral RNA after lysis (Fig. 3B).
An RNase activity was not detected in the velocity-gradient
purified virus preparation indicating successful purification
(Fig 3B). Extension of the assay incubation time did not enable
detection of an RNase activity (data not shown). Hence, viral
genomic RNA is stable when the highly purified virus is lysed with
detergent.
Reverse transcription efficiency is not improved in highly
purified HIV-1 in vitro
The stimulatory activity was purified using Sepharose CL-4B
gel filtration chromatography (Fig. 3C), which fractionates
globular protein with mass between 60,000 and 20,000,000
daltons. The activity was only present in the void volume (the
volume of mobile phase in the column) which separated the
activity from the bulk of the protein in the S100 whose mobility
was retarded by the column matrix. We refer to this activity as the
‘‘peak gel filtration’’ fraction (PGF). SDS-PAGE showed that the
PGF had an altered protein profile to the original S100 and an
increased proportion of high molecular mass proteins (Fig. 3D).
Equal amounts of both sucrose-cushion and velocity gradient
purified virus were stimulated several-fold by addition of either
S100 or the PGF fraction (Fig. 3E). The PGF gave a slightly
reduced late product synthesis compared to S100, which was seen
repeatedly, and was probably due to the diluting effects of the gel
filtration chromatography on the cell factor(s), but otherwise
performed similarly in ERT assays. As we demonstrated that
RNase activity had been removed from the purified virus (Fig 3B),
poor product synthesis in the ERT reaction after virion lysis could
not be attributed to RNase activity. A corollary of this conclusion
is that the cell factor(s) do not stimulate late product synthesis by
preventing degradation by an RNase present in the virus
preparation. Hence, some other activity or effect was responsible
for the enhanced late product synthesis when PGF was added.
A second hypothesis for a mechanism of action was that the cell
factor(s) stabilize the viral nucleoprotein complex after virion lysis.
To test this hypothesis, reactions were prepared containing intact
virions or detergent-lysed virions either with or without PGF, and
they were subjected to ultracentrifugation after incubation at 37uC
for 18 h (mimicking conditions used in the ERT assay). The pellet
was then resuspended in PBS overnight on ice and an 18 h ERT
reaction was performed on the resuspended pellet (Fig. 4A).
Detergent-lysed virions in the presence of the PGF were able to
generate nascent late product even after incubation at 37uC for
18 h, and a second incubation on ice overnight. The other
reactions were considerably diminished in terms of their ability to
generate nascent late products. However, all of the reactions made
strong-stop DNA indicating that prolonged treatment did not
disrupt the viral reverse transcription initiation complex. This
suggests that the cell stimulatory factor did not act by stabilizing
the nucleoprotein complex with respect to strong-stop DNA
synthesis, but enabled efficient reverse transcription following
negative strong stop DNA synthesis in agreement with previous
experiments.
Figure 2. Detergent lysis of virions. Virus was treated with
detergent (0.2 mM Triton X-100) in the presence or absence of S100.
At the time points shown, samples were subjected to ultracentrifuga-
tion, and the amount of p24 in the (A) supernatant and (B) pellet
fractions was determined. The data are representative of at least two
independent experiments.
doi:10.1371/journal.pone.0013229.g002
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ultracentrifugation. (B) The presence of a contaminating RNase was assessed by quantitative RT-PCR on the viral RNA after incubation at 37uC for 1 h.
(C) Gel filtration chromatography on the Jurkat cell lysate (S100 fraction). (D) SDS-PAGE on the S100 (S) and peak gel filtration (P) fraction. (E)
Comparison of the ability of sucrose-cushion and velocity-gradient purified virus to be stimulated to generate ‘‘second-strand transfer’’ late reverse
transcription products by S100, PGF fraction or control lysis buffer. The data shown are representative of at least two independent experiments. The
experiment was performed in triplicate reactions. The mean value and standard deviation of the mean is shown.
doi:10.1371/journal.pone.0013229.g003
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the cell factor(s)
The contaminating RNase which was present in the original
ERT system may have affected the kinetics of reverse transcription
product generation. Therefore, we performed additional ERT
assays with velocity gradient purified virus was used in ERT
reactions over a 22 h period (Fig. 4B–D), in the presence or
absence of PGF. The reaction displayed nearly identical kinetics to
the original time course experiment with respect to second strand
transfer DNA synthesis (Fig. 1B), and these reactions also resulted
in a 2-fold increase in first-strand transfer DNA (Fig. 4C).
As late product synthesis was more stimulated than early
product synthesis, this suggested that the cell factor(s) may also act
by assisting the elongation of DNA by reverse transcriptase. To
test this hypothesis, the efficiency of DNA synthesis in the env gene
region, approximately 2 kb from the U3 region, was determined
relative to the first-strand transfer DNA (i.e. measuring the U3-R
DNA copy number). Using this product enabled an analysis of
elongation without an intervening strand-transfer step. When PGF
was present in the reaction, there was a significant increase in the
level of env gene region DNA relative to first strand transfer DNA
(p,0.05, n=3) suggesting that elongation of reverse transcription
was improved by PGF (Fig. 4D).
Core stability does not affect cell factor stimulation
We considered that capsid may mediate the effects of the cell
stimulatory factor as capsid has been reported in RTCs [26,27]
and plays an important role in infection of non-dividing cells [28].
In addition, capsid was detected in variable but small amounts in
purified viral nucleoprotein complexes in our previous study [23].
To further investigate this possibility, we used HIV-1 with CA
mutations, which were reported to alter virion core stability [29],
in the modified ERT system to determine if reverse transcription
was affected by the addition of cell factors. Virion cores with the
mutations Q219A, P38A, R143A and E45A were previously
determined to be either less or more stable relative to wild-type by
the yield of cores purified from detergent-lysed virus (core
stabilities: Q219A,P38A,R143A,WT,E45A) [29]. These
HIV-1 mutants were defective for reverse transcription in cells
but not in a standard ERT assay [29]. Use of the PGF fraction in
reactions containing detergent with wild-type virions revealed that
lysis was complete, similarly to S100 (Fig. 5A). We then tested
Figure 4. Analysis of modified ERT reaction components. (A) Reaction components were combined as indicated for up to 18 h, followed by
ultracentrifugation, resuspension of the pellet, followed by ERT reaction and assay for strong-stop DNA (¤ and right y-axis) and second-strand
transfer shown as ‘‘efficiency’’ (gray columns and left y-axis) by quantitative PCR. The data shown are representative of at least two independent
experiments. (B–D) ERT reactions were incubated at 37uC for the indicated time, and reaction products analysed by quantitative PCR using the
indicated primer sets. For the indicated products, reaction efficiency is given relative to strong-stop (B and C) or first-strand transfer products (D). The
experiment was performed in triplicate reactions. The mean value and standard deviation of the mean is shown.
doi:10.1371/journal.pone.0013229.g004
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tion products either with or without added PGF fraction. As these
viruses were derived from cell lines transfected with plasmid, the
potential for contamination by plasmid carry-over was greater
than the culture-derived virus that was usually used in these
reactions. Hence, for these reactions a primer set flanking the
major splice donor site (‘‘full-length’’ primer set) was used for
quantitative PCR which increased the signal of nascent product
relative to plasmid carried-over from the transfection. Reverse
transcription of both wild-type and mutant viruses was stimulated
by addition of PGF to the reaction. There was no significant
correlation observed between previously determined core stability
and late reverse transcription product generation (Fig. 5B). Hence,
the CA mutations that affect of changes to core stability in vitro and
reverse transcription in cells did not affect reverse transcription in
the in vitro ERT assay containing stimulatory cell factor(s).
The cell lysate protects nascent reverse transcription
product from exogenous DNase I
It was reported that viral DNA in RTCs and PICs purified from
cells were partially resistant to nuclease activity [30,31,32]. Our
experiments suggested that the PGF fraction affected the viral
nucleoprotein complex so that reverse transcription could be
completed. The cell factors may have changed the structure of the
viral nucleoprotein complex, or acted directly on the viral nucleic
acids. To test these hypotheses, ERT reactions were assembled
that contained exogenous DNase I, which can degrade single and
double strand DNA (Fig. 6), and were incubated for 18 h. The
amount of viral DNA remaining was determined by quantitative
PCR using primers capable of detecting HIV-1 DNA containing
strong-stop sequences (Fig. 6). Nascent HIV-1 DNA was generated
in reactions without added DNase I (Fig. 6, reactions 1–2).
Reactions prepared with added DNase I and without lysate had no
measurable DNA indicating it was degraded (Fig. 6, reaction 3).
However, when DNase I was added with PGF, strong-stop DNA
was not digested during the overnight reaction (Fig 6, reactions 4).
Hence, using the partially-purified reaction components and
modified ERT reaction conditions, DNA product was protected
from nuclease degradation when the cell factor(s) were present.
Following this result, PGF was tested for the presence of an DNase
I inhibitor using a fluorometric assay [33]. This assay uses the
double-stranded DNA-specific dye PicoGreen to measure a
change in fluorescence after DNase I digestion enabling a
determination of activity. The PGF fraction (20 ml in a 100 ml
reaction) inhibited DNA degradation by approximately 80%.
Interestingly, heat inactivation of the PGF fraction at 80uC for
15 min reduced this inhibitory activity to approximately 20%
(Fig. 6B). Heat inactivation of the inhibitor suggests a proteina-
ceous activity, and is co-incidental with the heat-labile nature of
the cell stimulatory factor [23]. It’s unclear whether PGF protected
viral nucleic acids from DNase I activity directly or inhibited the
nuclease. In either case, this appears to be a general feature of the
cell factor(s) as viral factors were not required (Fig. 6B).
Discussion
Many of the post-entry events that regulate reverse transcription
of HIV-1 genomic RNA remain unresolved. Some of these events
most likely involve host cell proteins, and reverse transcription has
been linked to several cell factors (reviewed in [9,34]). We
previously identified an activity in Jurkat cells which stimulates the
synthesis of late reverse transcription products. In this study we
have taken steps to further define how this factor acts in our ERT
system. Further purification of components of our in vitro system
has enabled us to eliminate a contaminating RNase activity as
being responsible for poor late product synthesis in lysed virions.
Instead, addition of cell factor(s) significantly improved first strand
transfer and late product synthesis of reverse transcription, most
probably by improving DNA elongation by RT (Figs. 2 and 3).
Cell factors did not appear to enhance the stability of the viral
nucleoprotein complex initiation complex (Figs. 1 and 3A), but
could protect viral DNA from degradation by exogenous nucleases
(Fig. 6).
We eliminated a number of possible mechanisms by which the
cell factor(s) may improve late product synthesis. The S100 Jurkat
cell lysate stimulated the lysed virions to complete reverse
transcription rather than affected the ability to initiate reverse
transcription. Previously we had demonstrated lysis of the viral
membrane when 0.2 mM Triton X-100 was added [23]. Here we
speculated that virion lysis was altered such that the lysate reduced
the effective concentration of Triton X-100 in the reaction and this
Figure 5. Capsid and endogenous reverse transcription. (A)
Virus was lysed with detergent in the presence of S100 or PGF fraction
for 18 h, subjected to ultracentrifugation, the pellet was resuspended,
and the amount of p24 in the pellet and supernatant fractions was
measured. A no-detergent control was also included for comparison. (B)
Virus capsid mutants with cores of varying stabilities were used as a
source of virus in ERT reactions and their ability to generate late
products with and without added PGF fraction was determined by
quantitative PCR using the ‘‘full-length’’ primer set. The data shown are
representative of at two independent experiments.
doi:10.1371/journal.pone.0013229.g005
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completion. However, we showed that virion lysis was rapid and
there was no substantial temporal difference in the ability of
Triton-X100 to liberate soluble CA in the presence or absence of
S100 (Fig. 2). In addition, mutations in CA that affect virion core
stability in vitro, and down regulate reverse transcription in cells,
did not change the degree to which the wild type or mutant virus
could be stimulated by cell factor(s) (Fig. 5.). Hence, these results
do not support a role for capsid in mediating the stimulatory
effects of the cell factor(s) in our in vitro system. But this does not
excluded a role for capsid in reverse transcription in vivo.
To advance our insight of the mechanism of improved ERT by
cell factors, both the virus and stimulatory factor were subjected to
further purification. We used a 6–18% iodixanol gradient to purify
HIV-1 particles away from microvesicles which are known to
contain a various cell proteins and activities [25] to produce a
highly purified virus preparation. Velocity gradient purification
resulted in a reduction in a contaminating RNase activity (Fig. 3).
In combination with gel filtration-purified stimulatory factor from
the S100, where the stimulatory factor was present exclusively in
the column void volume (the PGF fraction), viral RNA was
relatively stable post-lysis in the presence of reaction components.
In spite of these substantial improvements to the ERT system, the
efficiency of late reverse transcription products by the viral
nucleoprotein complex remained low unless S100 or PGF fraction
was added to the reaction (Fig. 3). This indicated that the relatively
poor late product synthesis of detergent-lysed virions was not due
to the actions of an RNase activity; therefore, the lysate does not
act by neutralizing such an activity. Instead, the cell factor(s)
stimulates late product synthesis by some other means. We
observed that first strand-transfer process was completed in 2 h
without PGF, whereas first strand-transfer copies increased if PGF
was present (Fig. 4C). When we measured DNA levels in the env
region located approximately 2 kb from the first strand-transfer
region, comparison of DNA levels a marked increase in DNA
copies in env region between 2 and 22 h if PGF was present (i.e.
after the completion of first strand-transfer) suggesting that PGF
improved DNA elongation by RT (Fig. 4D). Further experiments
will be required to reveal how PGF affects RT interaction with the
primer-template.
Addition of S100 or PGF fraction to the ERT reaction in the
presence of exogenous DNase I protected the DNA product from
digestion. How this observation relates to the ability to stimulate
late product synthesis is currently unclear. The cell factor(s) may
change the biochemical properties of the viral nucleoprotein
complex such that it becomes nuclease resistant. It may bind
nucleic acids promoting reverse transcription DNA strand transfer
or elongation resulting in enhanced late product synthesis, or it
could somehow inactivate the nuclease activity (Fig. 6). In doing so
it may protect the DNA product from an exogenous nuclease.
While it is entirely possible that the observation of nuclease
resistant viral DNA in this study may be co-incidental, RTCs
isolated from infected cells make viral DNA that is resistant to
degradation by nucleases [30,31,32], making it possible that PGF
contains cell factor(s) relevant to RTCs purified from cells.
The stimulatory activity eluted in the void volume of a number
of different gel filtration media. We routinely used CL-4B medium
for purification in which globular molecules greater than 20 MDa
would be expected in the void volume. This suggests that the
stimulatory activity may be associated with a large complex or that
may be simply binding fragmented DNA present in the S100.
Regarding the former, some of the cell proteins linked to HIV-1
reverse transcription by a siRNA genomic screen were compo-
nents of large interacting networks suggesting multi-protein
complexes [2]. Some of these proteins were also nucleic acid
binding proteins or involved in DNA repair which may potentially
protect a DNA product from a nuclease activity. The latter
possibility, association with a DNA fragment, is also consistent
with a DNA binding protein. We attempted to remove DNA and
RNA from the S100 using micrococcal nucease before gel
filtration, but this treatment did not shift the elution profile of
PGF activity (data not shown). We cannot exclude the possibility
that nuclease resistant DNA was present in the S100. We are
currently in the process of purifying the cell factor(s), and its
identification should elucidate its composition and the means by
which it enhances reverse transcription in HIV-1 in vitro. The next
Figure 6. The Jurkat cell lysate contains an inhibitor of DNase I activity. (A) ERT reactions with modified components were prepared as
shown with or without exogenous DNase I, incubated 18 h, and strong-stop DNA products determined by real-time PCR. (B) Native (PGF) or heat-
denature (HI-PGF) material was assayed for its ability to inhibit DNase I. The data shown are representative of two independent experiments.
doi:10.1371/journal.pone.0013229.g006
Cell Factors and HIV
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early infection in vivo.
In conclusion, endogenous reverse transcription could be
strongly stimulated by the addition of partially purified cell
factor(s) that had two notable effects: increased ability to undergo
first strand transfer and elongation that could account for the
increase in late products, and the viral DNA became resistant to
exogenous DNase I activity. Further purification will be required
to identify the cellular proteins that responsible, so that their
relevance can be determined in the context of cell infection.
Methods
Cell lines and virus culture
All cells were grown in RPMI1640 supplemented with 10%
NBS and penicillin-streptomycin at 37uCi n5 %C O 2 (standard
conditions). The MAGI CXCR4-expressing cell line (NIH AIDS
Research and Reference Reagent Program) was additionally
supplemented with 0.2 mg/ml geneticin and 0.1 mg/ml hygro-
mycin B. Stocks of HIVNL4.3 (National Institutes of Health AIDS
Research and Reference Reagent Program) or HIV-1 containing
capsid mutations (a kind gift of Christoper Aiken) were generated
by transfection of the corresponding proviral DNA using
Lipofectamine
TM 2000 (Invitrogen) or FuGENE6 (Roche) into
HEK293T cells (a gift from Dr. Richard Gaynor, Eli Lilly and
Co., USA) according to the manufacturer’s recommendations.
After 4 h incubation, the transfection mix was removed and the
cells were washed with fresh medium 4 times. Standard growth
medium was then added. Cell culture supernatants were removed
at 48 or 72 h post-transfection, centrifuged (200 g, 10 min), and
the supernatant was filtered (0.45 mm) and stored in 1 ml aliquots
at 280uC. Amplification of the HIVNL4.3 stock in the MAGI cell
line was as described previously [23]. Briefly, the cells were
infected with HIVNL4-3 (250 ng p24), incubated for 6 days,
harvested and stored as above. Virus was concentrated by
ultracentrifugation (Beckman Coulter Sw41Ti, 100000 g,2 h ,
4uC) on a 20% sucrose cushion. If the virus was from a stock
generated by transfection without prior amplification in MAGI
cells, ultracentrifugation was followed by a 1 ml wash in PBS. The
pellet was resuspended overnight in sterile PBS in one-tenth of the
original culture volume, and stored in 50 ml aliquots at 280uC
until needed. The concentrated virus stock was further purified by
velocity gradient ultracentrifugation as in Cantin et al. (2008) [25]
using Optiprep (Axis-Shield) diluted from 6% to 18% in eleven
1.2% steps in PBS buffer. Optiprep was added in layers of 820 ml,
starting with the 18% layer at the bottom and progressively
decreasing to 6% and centrifuged at 100,000 g for 3 h (Beckman
Coulter Sw41Ti, 28000 rpm, 4uC). Fractions (820 ml) were
collected from the top of the tube. The fractions were assayed
for p24 antigen and the peak fractions were pooled and stored in
aliquots at 280uC.
ERT assays
Endogenous reverse transcription (ERT) reactions were per-
formed by addition of virus (equivalent to 10 ng p24 unless
otherwise stated) to a mixture containing 10 mM Tris, pH 7.4,
10 mM MgCl2, 200 mM each dNTP and 0.2 mM Triton X-100 in
nuclease-free water (final volume of 50 ml) for 18–20 h at 37uC.
Detergent was the last component added. A no-nucleotide control
reaction was always included and was negligible or the data were
discarded. If relevant, the amount of S100 or PGF fraction added
varied but was typically 20 mg or 1.5 mg, respectively. Reactions
products were extracted, once with an equal phenol:chlorofor-
m:iso-amyl alcohol (25:24:1) and once with chloroform. The
extracts were ethanol precipitated, washed with 70% ethanol,
dried and resuspended in 100 ml of 0.1 mM EDTA. Purified
reaction products (5 ml) were added to the reaction mix containing
0.4 mM of each primer, SYBR Green I, 30 U/ml Platinum Taq
polymerase, 20 mM Tris-HCl pH 8.4, 50 mM KCl, 3 mM
MgCl2, 200 mM each dNTP, 20 U/l uracil-N-glycosylase (Invi-
trogen) in a final volume of 15 ml. When reactions contained
DNase I it was added at 500 U/ml. A no-DNA control (5 mlo f
0.1 mM EDTA, pH 8.0) was also included. Standard primer sets
used for amplification were: strong-stop DNA, forward primer (59-
dGGTCTCTCTGGTTAGACCA-39) and reverse primer (59-dA-
AGCAGTGGGTTCCCTAGTTAG-39) and; first-strand transfer,
forward primer (59-dAGCAGCTGCTTTTTGCCTGTACT-39)
and reverse primer (59-dACACAACAGACGGGCACACAC-39);
full-length minus strand, forward primer (59-dCAAGTAG-
TGTGTGCCCGTCTGTT-39) and reverse primer (59-dCC-
TGCGTCGAGAGAGCTCCTCTGG-39); second-strand trans-
fer forward primer (59-dAGCAGCTGCTTTTTGCCTGTACT)
and reverse primer (59-dCCTGCGTCGAGAGAGCTCCTC-
TGG-39); and envelope forward primer (59-dGGTCCGAGA-
TCTTCAGACCT-39) and reverse primer (59-dGTGGGTG-
CTACTCCTAATGG-39). The mixes were subjected to cycling:
[50uC, 2 min; 95uC, 2 min]1[95uC, 15 sec; 65uC, 30 sec]40 on a
Rotor-Gene 3000
TM thermocycler (Corbett) set to collect SYBR
fluorescent signal after the 65uC step. Copy number (proviral
equivalents) was determined by reference to a standard curve
prepared by dilution of plasmid pNL4.3.
Detergent treatment and p24 assay
Triton X-100 detergent was added at room temperature to
virions at the concentrations indicated in the text. The samples
were then immediately diluted to 10 ml in 0.1 mg/ml BSA
dissolved in PBS and centrifuged at 100,000 g for 2 h (Beckman
Sw41Ti rotor, 28000 rpm, 4uC). An untreated virus control,
which was harvested at 0 h, was included. Pre-centrifugation,
supernatant and pellet fractions were assayed by ERT or for p24
antigen using RETROtek HIV-1 p24 antigen ELISA (Zeptome-
trix) according to the manufacturer’s instructions.
Preparation of Jurkat cell lysates and gel filtration
Preparation of a cleared lysate from Jurkat cells (S100) was as
described previously [23]. All buffers contained protease inhibitor
cocktail (Roche). Cells grown to near-confluence were washed and
lysed using the Dounce homogeniser. The lysate was cleared by
centrifugation in a refrigerated microfuge (4uC, 12000 rpm,
10 min) followed by ultracentrifugation at 100000 g for 1 h
(Beckman Coulter Sw41Ti rotor, 28000 rpm, 4uC). The S100
fraction was partially purified by gel filtration chromatography
using CL-4B medium (Sigma). The fractions were assayed by ERT
as above and the majority of the activity resided in the void
volume material as determined by co-fractionation with chromo-
somal DNA. Protein concentration was measured using a
commercially available Bradford assay (Bio-Rad, CA, USA). The
final protein concentration varied from preparation to preparation
but was typically 4 mg/ml for S100 lysate and 0.15 mg/ml for the
void volume fraction.
Genomic viral RNA assay
Viral RNA stability was measured by combining the ERT
reaction components at 37uC for 1 h. Reactions were extracted as
for the ERT reaction above, resuspended in 20 ml of 0.1 mM
EDTA. cDNA synthesis was performed on the extracted RNA
using Superscript III (Invitrogen) and primer (59-dACACAACA-
GACGGGCACACAC -39) according to the manufacturer’s
Cell Factors and HIV
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terminated by heating at 75uC for 15 min. The cDNA was diluted
1:10 and used as a template for the quantitative detection of
strong-stop DNA as for the conditions of the ERT assay using
forward and reverse primers as above.
PicoGreen DNase I assay
Determination of DNase I activity was as described by Choi and
Szoka [33]. The reaction contained the sample, 50 pg DNase I,
herring-sperm DNA (0.2 mg) in a reaction containing 25 mM
HEPES pH 7.4, 4 mM CaCl2, 4 mM MgCl2 in a final volume of
100 ml. The reaction was incubated for 30 min at 37uC. To detect
double-stranded DNA, a concentrated stock of PicoGreen was
diluted 1:200 and added to the reaction mixture (100 ml). The
fluorescence intensity was determined by excitation at 485 nm and
detection at 520 nm. A heat-inactivation control was prepared by
heating the PGF fraction at 80uC for 15 min. The change in
fluorescence was determined by subtracting the fluorescence of the
sample from the excitation fluorescence of a no-DNase I control.
In the case of the PGF fraction samples, the excitation fluorescence
was subtracted from a control containing the same sample
contents but without DNase I. The DNase I activity was then
determined with reference to a standard curve (0–50 pg DNase I).
Gel electrophoresis
Protein samples were subjected to electrophoresis by 10% SDS-
PAGE according to Sambrook et al [35]. Proteins were detected by
using Bio-Safe Coomassie stain (Bio-Rad) according to the
manufacturer’s instructions.
Acknowledgments
Thanks to Christopher Aiken for his kind gift of the virus constructs with
capsid mutations.
Author Contributions
Conceived and designed the experiments: DW DH. Performed the
experiments: DW KW. Analyzed the data: DW DH. Contributed
reagents/materials/analysis tools: DH. Wrote the paper: DW DH.
References
1. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008)
Identification of host proteins required for HIV infection through a functional
genomic screen. Science 319: 921–926.
2. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, et al. (2008) Global
analysis of host-pathogen interactions that regulate early-stage HIV-1 replica-
tion. Cell 135: 49–60.
3. Ye Y, De Leon J, Yokoyama N, Naidu Y, Camerini D (2005) DBR1 siRNA
inhibition of HIV-1 replication. Retrovirology 2: 63.
4. Yeung ML, Houzet L, Yedavalli VS, Jeang KT (2009) A genome-wide short
hairpin RNA screening of jurkat T-cells for human proteins contributing to
productive HIV-1 replication. J Biol Chem 284: 19463–19473.
5. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, et al. (2008) Genome-scale
RNAi screen for host factors required for HIV replication. Cell Host Microbe 4:
495–504.
6. Hamamoto S, Nishitsuji H, Amagasa T, Kannagi M, Masuda T (2006)
Identification of a novel human immunodeficiency virus type 1 integrase
interactor, Gemin2, that facilitates efficient viral cDNA synthesis in vivo. J Virol
80: 5670–5677.
7. Lemay J, Maidou-Peindara P, Bader T, Ennifar E, Rain JC, et al. (2008) HuR
interacts with human immunodeficiency virus type 1 reverse transcriptase, and
modulates reverse transcription in infected cells. Retrovirology 5: 47.
8. Lemay J, Maidou-Peindara P, Cancio R, Ennifar E, Coadou G, et al. (2008)
AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse
transcription. J Mol Biol 383: 783–796.
9. Warrilow D, Tachedjian G, Harrich D (2009) Maturation of the HIV reverse
transcription complex: puting the jigsaw together. Rev Med Virol 19: 324–337.
10. Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP (1994) Binding and
stimulation of HIV-1 integrase by a human homolog of yeast transcription factor
SNF5 [see comments]. Science 266: 2002–2006.
11. Sorin M, Cano J, Das S, Mathew S, Wu X, et al. (2009) Recruitment of a
SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral
replication. PLoS Pathog 5: e1000463.
12. Farnet CM, Bushman FD (1997) HIV-1 cDNA integration: requirement of
HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88:
483–492.
13. Iordanskiy S, Berro R, Altieri M, Kashanchi F, Bukrinsky M (2006)
Intracytoplasmic maturation of the human immunodeficiency virus type 1
reverse transcription complexes determines their capacity to integrate into
chromatin. Retrovirology 3: 4.
14. Li L, Olvera JM, Yoder KE, Mitchell RS, Butler SL, et al. (2001) Role of the
non-homologous DNA end joining pathway in the early steps of retroviral
infection. EMBO J 20: 3272–3281.
15. Lin CW, Engelman A (2003) The barrier-to-autointegration factor is a
component of functional human immunodeficiency virus type 1 preintegration
complexes. J Virol 77: 5030–5036.
16. Llano M, Vanegas M, Fregoso O, Saenz D, Chung S, et al. (2004) LEDGF/p75
determines cellular trafficking of diverse lentiviral but not murine oncoretroviral
integrase proteins and is a component of functional lentiviral preintegration
complexes. J Virol 78: 9524–9537.
17. Boone LR, Skalka A (1980) Two species of full-length cDNA are synthesized in
high yield by melittin-treated avian retrovirus particles. Proc Natl Acad Sci U S A
77: 847–851.
18. Boone LR, Skalka AM (1981) Viral DNA synthesized in vitro by avian retrovirus
particles permeabilized with melittin. I. Kinetics of synthesis and size of minus-
and plus-strand transcripts. J Virol 37: 109–116.
19. Borroto-Esoda K, Boone LR (1991) Equine infectious anemia virus and human
immunodeficiency virus DNA synthesis in vitro: characterization of the
endogenous reverse transcriptase reaction. J Virol 65: 1952–1959.
20. Borroto-Esoda K, Boone LR (1994) Development of a human immunodefi-
ciency virus-1 in vitro DNA synthesis system to study reverse transcriptase
inhibitors. Antiviral Res 23: 235–249.
21. Yong WH, Wyman S, Levy JA (1990) Optimal conditions for synthesizing
complementary DNA in the HIV-1 endogenous reverse transcriptase reaction.
Aids 4: 199–206.
22. Narayan S, Young JA (2004) Reconstitution of retroviral fusion and uncoating in
a cell-free system. Proc Natl Acad Sci U S A 101: 7721–7726.
23. Warrilow D, Meredith L, Davis A, Burrell C, Li P, et al. (2008) Cell factors
stimulate human immunodeficiency virus type 1 reverse transcription in vitro.
J Virol 82: 1425–1437.
24. Warrilow D, Stenzel D, Harrich D (2007) Isolated HIV-1 core is active for
reverse transcription. Retrovirology 4: 77.
25. Cantin R, Diou J, Belanger D, Tremblay AM, Gilbert C (2008) Discrimination
between exosomes and HIV-1: purification of both vesicles from cell-free
supernatants. J Immunol Methods 338: 21–30.
26. Arhel NJ, Souquere-Besse S, Munier S, Souque P, Guadagnini S, et al. (2007)
HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex
at the nuclear pore. Embo J 26: 3025–3037.
27. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, et al. (2002)
Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 159:
441–452.
28. Yamashita M, Perez O, Hope TJ, Emerman M (2007) Evidence for direct
involvement of the capsid protein in HIV infection of nondividing cells. PLoS
Pathog 3: 1502–1510.
29. Forshey BM, von Schwedler U, Sundquist WI, Aiken C (2002) Formation of a
human immunodeficiency virus type 1 core of optimal stability is crucial for viral
replication. J Virol 76: 5667–5677.
30. Fassati A, Goff SP (1999) Characterization of intracellular reverse transcription
complexes of Moloney murine leukemia virus. J Virol 73: 8919–8925.
31. Nermut MV, Fassati A (2003) Structural analyses of purified human
immunodeficiency virus type 1 intracellular reverse transcription complexes.
J Virol 77: 8196–8206.
32. Khiytani DK, Dimmock NJ (2002) Characterization of a human immunode-
ficiency virus type 1 pre-integration complex in which the majority of the cDNA
is resistant to DNase I digestion. J Gen Virol 83: 2523–2532.
33. Choi SJ, Szoka FC (2000) Fluorometric determination of deoxyribonuclease I
activity with PicoGreen. Anal Biochem 281: 95–97.
34. Warren K, Warrilow D, Harrich D (2009) Reverse transcriptase and cellular
factors: regulators of HIV-1 reverse transcription. Viruses 1: 873–894.
35. Sambook J, Fritsch EF, T M (1989) Molecular Cloning: A Laboratory Manual.
Second Edition.
Cell Factors and HIV
PLoS ONE | www.plosone.org 9 October 2010 | Volume 5 | Issue 10 | e13229